PACS director Hancock sells 161,068 shares

PACS Group director and ten percent owner Mark Hancock reported a mix of stock sales and a new equity award.

Rhea-AI Filing Summary

PACS Group director and ten percent owner Mark Hancock reported a mix of stock sales and a new equity award. On July 6, 2026, he sold 142,163 shares of common stock at a weighted average price of $45.3343 per share. He also sold 12,825 shares on July 2, 2026 at $45.0129 and 6,080 shares on July 1, 2026 at $45.0191, all as open-market transactions under a pre-arranged Rule 10b5-1 trading plan.

Following these trades, Hancock directly held 53,945,816 shares of PACS Group common stock. Separately, on July 1, 2026 he received 4,287 restricted stock units, each convertible into one share of common stock, vesting 100% on the earlier of July 1, 2027 or the next annual meeting, subject to his continued service.

Insider Trade Summary 10b5-1

Net Seller: 161,068 shares

Net Sell 4 txns

Insider Hancock Mark

Role Director, 10% Owner

Sold 161,068 shs ($7.30M)

Type	Security	Shares	Price	Value
Sale	Common Stock	142,163	$45.3343	$6.44M
Sale	Common Stock	12,825	$45.0129	$577K
Grant/Award	Common Stock	4,287	$0.00	$0.00
Sale	Common Stock	6,080	$45.0191	$274K

Holdings After Transaction: Common Stock — 53,945,816 shares (Direct)

Footnotes (5)

1. F1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will vest on the earlier to occur of (i) July 1, 2027 and (ii) the date of the next annual meeting following the grant date, subject to the Reporting Person's continued service to the Issuer.
2. F2. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026.
3. F3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.075 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. F4. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.115 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. F5. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.88 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold July 6, 2026: 142,163 shares Shares sold July 2, 2026: 12,825 shares Shares sold July 1, 2026: 6,080 shares +3 more

6 metrics

Shares sold July 6, 2026 142,163 shares Open-market sale at $45.3343 per share

Shares sold July 2, 2026 12,825 shares Open-market sale at $45.0129 per share

Shares sold July 1, 2026 6,080 shares Open-market sale at $45.0191 per share

Total shares sold 161,068 shares Aggregate of three open-market sales

Shares held after transactions 53,945,816 shares Direct PACS Group common stock ownership post-July 6, 2026 sale

RSUs granted 4,287 RSUs Award on July 1, 2026, vesting by July 1, 2027 or next annual meeting

Key Terms

Rule 10b5-1 trading plan, restricted stock units ("RSUs"), weighted average price, annual meeting

4 terms

Rule 10b5-1 trading plan regulatory

"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

restricted stock units ("RSUs") financial

"Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

annual meeting regulatory

"100% of the RSUs will vest on the earlier to occur of (i) July 1, 2027 and (ii) the date of the next annual meeting following the grant date."

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Mark Hancock report for PACS Group (PACS)?

Mark Hancock reported selling 161,068 PACS Group common shares in three open-market transactions around $45 per share, and receiving 4,287 restricted stock units that may vest into shares if service conditions are met by July 1, 2027 or the next annual meeting.

How many PACS Group (PACS) shares did Mark Hancock sell and at what prices?

He sold 142,163 shares at $45.3343, 12,825 shares at $45.0129, and 6,080 shares at $45.0191. Footnotes state these reported prices are weighted averages for multiple trades within narrow ranges around $45 per PACS Group common share.

Did Mark Hancock’s PACS Group (PACS) sales occur under a Rule 10b5-1 trading plan?

Yes. A footnote explains the sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 11, 2026. Such plans schedule trades in advance, indicating these transactions followed a preset trading arrangement rather than ad hoc market timing.

What PACS Group (PACS) equity award did Mark Hancock receive in this Form 4?

He received 4,287 restricted stock units, each convertible into one PACS Group common share upon vesting. The RSUs vest 100% on the earlier of July 1, 2027 or the next annual meeting, assuming Hancock continues to provide service to PACS Group.

How many PACS Group (PACS) shares does Mark Hancock hold after these transactions?

After the reported July 6, 2026 sale, Hancock directly held 53,945,816 PACS Group common shares. This figure reflects his remaining direct ownership position following the disclosed open-market sales and provides context for the scale of the transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 06:50 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hancock Mark

(Last) (First) (Middle)

C/O PACS GROUP, INC.

90 S. 400 W. SUITE 700

(Street)

SALT LAKE CITY UTAH 84101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		4,287(1)	A	$0	54,106,884	D
Common Stock	07/01/2026		S(2)		6,080	D	$45.0191(3)	54,100,804	D
Common Stock	07/02/2026		S(2)		12,825	D	$45.0129(4)	54,087,979	D
Common Stock	07/06/2026		S(2)		142,163	D	$45.3343(5)	53,945,816	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will vest on the earlier to occur of (i) July 1, 2027 and (ii) the date of the next annual meeting following the grant date, subject to the Reporting Person's continued service to the Issuer.

2. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026.

3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.075 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.115 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.88 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ John Mitchell, Attorney-in-Fact	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)